Fig. 4: Kaplan–Meier analyses of disease-free survival (DFS) and overall survival (OS) according to different RS groups in patients with gastric cancer. | Nature Communications

Fig. 4: Kaplan–Meier analyses of disease-free survival (DFS) and overall survival (OS) according to different RS groups in patients with gastric cancer.

From: Noninvasive imaging of the tumor immune microenvironment correlates with response to immunotherapy in gastric cancer

Fig. 4

a Disease-free survival according to different RS groups in the training cohort, internal validation cohort 1, internal validation cohort 2, and the external validation cohort. b Overall survival according to different RS groups in the training cohort, internal validation cohort 1, internal validation cohort 2, and the external validation cohort. RS-L: RS-Low group, RS-M: RS-Middle group, RS-H: RS-High group. Comparisons of the above progression survival curves were performed with a two-sided log-rank test. Dashed lines around the survival curves represent 95% confidence intervals. Source data are provided as a Source data file.

Back to article page